NASDAQ : SVRA
Savara Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 4.82 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.22B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cost of Revenue | 86.84M | 81.40M | 78.03M | 44.26M | 27.88M | 28.99M |
| Gross Profit | -86.84M | -81.40M | -78.03M | -44.26M | -27.88M | -28.99M |
| Selling, General & Admin | 56.71M | 42.06M | 25.04M | 15.67M | 10.93M | 12.35M |
| Other Operating Expenses | -853.00K | -784.00K | -797.00K | -797.00K | -796.00K | -844.00K |
| Operating Expenses | 55.93M | 41.36M | 24.37M | 14.95M | 10.16M | 11.64M |
| Operating Income | -142.78M | -122.76M | -102.40M | -59.21M | -38.04M | -40.63M |
| Interest Expense | -88.00K | -2.28M | ||||
| Interest & Investment Income | 3.65M | 4.16M | 6.47M | 4.44M | ||
| Currency Exchange Gain (Loss) | -163.00K | 310.00K | 51.00K | 76.00K | -19.00K | -99.00K |
| Other Non Operating Income (Expenses) | -23.00K | |||||
| EBT Excluding Unusual Items | -139.31M | -118.29M | -95.88M | -54.70M | -38.15M | -43.01M |
| Other Unusual Items | -546.00K | |||||
| Pretax Income | -139.31M | -118.84M | -95.88M | -54.70M | -38.15M | -43.01M |
| Net Income | -139.31M | -118.84M | -95.88M | -54.70M | -38.15M | -43.01M |
| Net Income to Common | -139.31M | -118.84M | -95.88M | -54.70M | -38.15M | -43.01M |
| Shares Outstanding (Basic) | 240.96M | 222.39M | 198.19M | 165.20M | 152.77M | 152.77M |
| Shares Outstanding (Diluted) | 240.96M | 222.39M | 198.19M | 165.20M | 152.77M | 152.77M |
| EPS (Basic) | -0.58 | -0.53 | -0.48 | -0.33 | -0.25 | -0.28 |
| EPS (Diluted) | -0.58 | -0.53 | -0.48 | -0.33 | -0.25 | -0.28 |
| Free Cash Flow | -110.66M | -101.06M | -89.11M | -51.36M | -34.56M | -40.14M |
| Free Cash Flow Per Share | -0.46 | -0.45 | -0.45 | -0.31 | -0.23 | -0.26 |
| EBITDA | -142.70M | -122.68M | -102.27M | -59.13M | -38.01M | -40.50M |
| D&A For EBITDA | 76.00K | 87.00K | 130.00K | 77.00K | 31.00K | 136.00K |
| EBIT | -142.78M | -122.76M | -102.40M | -59.21M | -38.04M | -40.63M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 41.80M | 33.18M | 15.13M | 26.59M | 52.10M | 34.01M |
| Short-Term Investments | 133.01M | 203.41M | 181.65M | 136.01M | 73.85M | 127.52M |
| Cash & Short-Term Investments | 174.81M | 236.59M | 196.78M | 162.60M | 125.95M | 161.53M |
| Other Receivables | 1.08M | 1.25M | 1.04M | 1.00M | 954.00K | 1.14M |
| Receivables | 1.08M | 1.25M | 1.04M | 1.00M | 954.00K | 1.14M |
| Prepaid Expenses | 294.00K | 215.00K | 131.00K | 176.00K | 231.00K | 427.00K |
| Other Current Assets | 2.13M | 3.55M | 4.18M | 2.17M | 1.82M | 1.90M |
| Total Current Assets | 178.32M | 241.62M | 202.13M | 165.95M | 128.95M | 165.00M |
| Property, Plant & Equipment | 641.00K | 100.00K | 165.00K | 270.00K | 51.00K | 324.00K |
| Other Intangible Assets | 11.29M | 11.64M | 10.34M | 10.96M | 10.66M | 11.27M |
| Other Long-Term Assets | 1.89M | 84.00K | 242.00K | 387.00K | 116.00K | |
| Total Assets | 192.14M | 253.44M | 212.88M | 177.56M | 139.78M | 176.60M |
| Accounts Payable | 7.00M | 5.76M | 4.54M | 3.50M | 1.33M | 1.44M |
| Accrued Expenses | 9.92M | 14.27M | 10.06M | 6.95M | 4.47M | 4.75M |
| Current Portion of Long-Term Debt | 8.33M | |||||
| Current Portion of Leases | 298.00K | 7.00K | 116.00K | 143.00K | 64.00K | 135.00K |
| Other Current Liabilities | 385.00K | 362.00K | ||||
| Total Current Liabilities | 17.60M | 20.40M | 14.72M | 10.60M | 5.87M | 14.66M |
| Long-Term Debt | 29.31M | 29.91M | 26.62M | 26.35M | 26.08M | 17.32M |
| Long-Term Leases | 796.00K | 87.00K | ||||
| Other Long-Term Liabilities | 770.00K | 247.00K | 54.00K | 117.00K | ||
| Total Liabilities | 48.48M | 50.30M | 41.43M | 37.19M | 32.00M | 32.10M |
| Common Stock | 204.00K | 204.00K | 173.00K | 140.00K | 116.00K | 116.00K |
| Additional Paid-In Capital | 829.59M | 811.10M | 661.28M | 533.87M | 446.94M | 444.90M |
| Retained Earnings | -685.60M | -608.09M | -489.25M | -393.37M | -338.67M | -300.52M |
| Comprehensive Income & Other | -534.00K | -87.00K | -750.00K | -271.00K | -605.00K | 5.00K |
| Total Common Equity | 143.66M | 203.13M | 171.45M | 140.37M | 107.78M | 144.50M |
| Shareholders' Equity | 143.66M | 203.13M | 171.45M | 140.37M | 107.78M | 144.50M |
| Total Liabilities & Equity | 192.14M | 253.44M | 212.88M | 177.56M | 139.78M | 176.60M |
| Total Debt | 30.41M | 29.91M | 26.82M | 26.49M | 26.14M | 25.79M |
| Net Cash (Debt) | 144.41M | 206.68M | 169.96M | 136.11M | 99.81M | 135.74M |
| Net Cash Per Share | 0.60 | 0.93 | 0.86 | 0.82 | 0.65 | 0.89 |
| Filing Date Shares Outstanding | 254.14M | 253.26M | 216.26M | 182.55M | 152.80M | 152.77M |
| Total Common Shares Outstanding | 254.08M | 253.17M | 216.05M | 182.54M | 152.78M | 152.77M |
| Working Capital | 160.72M | 221.22M | 187.41M | 155.35M | 123.09M | 150.34M |
| Book Value Per Share | 0.57 | 0.80 | 0.79 | 0.77 | 0.71 | 0.95 |
| Tangible Book Value | 132.37M | 191.50M | 161.11M | 129.41M | 97.12M | 133.22M |
| Tangible Book Value Per Share | 0.52 | 0.76 | 0.75 | 0.71 | 0.64 | 0.87 |
| Machinery | 2.10M | 1.99M | 1.95M | 1.83M | 2.00M | |
| Leasehold Improvements | 333.00K | 333.00K | 333.00K | 145.00K | 153.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -139.31M | -118.84M | -95.88M | -54.70M | -38.15M | -43.01M |
| Depreciation & Amortization | 234.00K | 245.00K | 275.00K | 175.00K | 167.00K | 367.00K |
| Other Amortization | 457.00K | 453.00K | 271.00K | 271.00K | 334.00K | 552.00K |
| Loss (Gain) From Sale of Investments | -1.90M | -2.87M | -5.44M | -4.98M | 75.00K | 1.60M |
| Stock-Based Compensation | 27.27M | 14.42M | 9.86M | 4.18M | 2.04M | 3.26M |
| Other Operating Activities | 58.00K | 546.00K | -76.00K | 19.00K | -4.00K | |
| Change in Accounts Payable | 3.61M | 4.81M | 4.20M | 4.54M | -319.00K | -1.76M |
| Change in Other Net Operating Assets | -798.00K | 195.00K | -2.37M | -468.00K | 1.28M | -1.08M |
| Operating Cash Flow | -110.38M | -101.04M | -89.09M | -51.06M | -34.55M | -40.08M |
| Capital Expenditures | -280.00K | -22.00K | -25.00K | -296.00K | -9.00K | -57.00K |
| Investment in Securities | -441.00K | -18.42M | -39.92M | -56.82M | 52.65M | -69.40M |
| Investing Cash Flow | -721.00K | -18.44M | -39.94M | -57.12M | 52.65M | -69.46M |
| Long-Term Debt Issued | 29.60M | 26.44M | ||||
| Long-Term Debt Repaid | -27.23M | -26.35M | ||||
| Net Debt Issued (Repaid) | 1.00K | 2.37M | 88.00K | |||
| Issuance of Common Stock | 140.59M | 140.58M | 124.73M | 72.11M | 2.00K | 85.91M |
| Repurchase of Common Stock | -5.06M | -5.14M | -995.00K | -1.21M | -3.00K | -78.00K |
| Other Financing Activities | -6.16M | 11.87M | 34.98M | |||
| Financing Cash Flow | 135.53M | 137.81M | 117.58M | 82.78M | 87.00K | 120.81M |
| Foreign Exchange Rate Adjustments | -66.00K | -277.00K | -5.00K | -118.00K | -90.00K | -137.00K |
| Net Cash Flow | 24.36M | 18.05M | -11.46M | -25.52M | 18.09M | 11.13M |
| Free Cash Flow | -110.66M | -101.06M | -89.11M | -51.36M | -34.56M | -40.14M |
| Free Cash Flow Per Share | -0.46 | -0.45 | -0.45 | -0.31 | -0.23 | -0.26 |
| Levered Free Cash Flow | -57.19M | -55.52M | -51.47M | -28.37M | -21.22M | -25.24M |
| Unlevered Free Cash Flow | -57.64M | -55.97M | -51.74M | -28.64M | -21.50M | -24.36M |
| Cash Interest Paid | 2.62M | 3.20M | 2.12M | 2.04M | 1.61M | 1.97M |
| Change in Working Capital | 2.81M | 5.00M | 1.83M | 4.07M | 960.00K | -2.85M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.22B | 1.49B | 660.79M | 844.77M | 236.80M | 189.22M |
| Enterprise Value | 1.08B | 1.39B | 467.73M | 703.06M | 128.78M | 44.00M |
| Last Close Price | 4.82 | 6.03 | 3.07 | 4.70 | 1.55 | 1.24 |
| PB Ratio | 8.52 | 7.33 | 3.85 | 6.02 | 2.20 | 1.31 |
| P/TBV Ratio | 9.31 | 7.78 | 4.10 | 6.53 | 2.44 | 1.42 |
| Debt / Equity Ratio | 0.21 | 0.15 | 0.16 | 0.19 | 0.24 | 0.18 |
| Net Debt / Equity Ratio | -1.00 | -1.02 | -0.99 | -0.97 | -0.93 | -0.94 |
| Net Debt / EBITDA Ratio | 1.01 | 1.69 | 1.66 | 2.30 | 2.63 | 3.35 |
| Net Debt / FCF Ratio | 1.30 | 2.04 | 1.91 | 2.65 | 2.89 | 3.38 |
| Quick Ratio | 9.99 | 11.66 | 13.44 | 15.44 | 21.63 | 11.10 |
| Current Ratio | 10.13 | 11.85 | 13.73 | 15.66 | 21.98 | 11.26 |
| Return on Equity (ROE) | -105.48% | -63.45% | -61.50% | -44.09% | -30.25% | -41.19% |
| Return on Assets (ROA) | -50.14% | -32.91% | -32.78% | -23.32% | -15.03% | -18.51% |
| Return on Capital Employed (ROCE) | -81.80% | -52.70% | -51.70% | -35.50% | -28.40% | -25.10% |
| Earnings Yield | -12.01% | -7.98% | -14.51% | -6.48% | -16.11% | -22.73% |
| FCF Yield | -8.98% | -6.78% | -13.49% | -6.08% | -14.60% | -21.21% |
| Buyback Yield / Dilution | -12.04% | -12.21% | -19.97% | -8.14% | -0.00% | -151.64% |